Browse the complete record of transactions filed by Pridgen William, Director. Insider active across 1 companies, notably Virios Therapeutics, Inc.. Aggregated, 12 disclosures have been published. Total volume traded: €235k. The latest transaction was filed on 18 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
William Pridgen serves as a Director at Virios Therapeutics, Inc. As a board member, he participates in overseeing operations and strategic decision-making. His experience in the pharmaceutical sector is valuable in guiding Virios' activities. William Pridgen is committed to supporting the company's mission and objectives.
